Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB507 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human BMP-6 Monoclonal Antibody (Clone 74219)
- Antibody type
- Monoclonal
- Antigen
- Chinese hamster ovary cell line CHO-derived recombinant human BMP-6, Arg296-His428
- Description
- Protein A or G purified from ascites
- Reactivity
- Human
- Host
- Mouse
- Antigen sequence
Q4VBA3
- Isotype
- IgG
- Vial size
- 500 µg
Submitted references Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.
TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice.
Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Blanchette-Farra N, Kita D, Konstorum A, Tesfay L, Lemler D, Hegde P, Claffey KP, Torti FM, Torti SV
Oncogene 2018 Jul;37(29):4013-4032
Oncogene 2018 Jul;37(29):4013-4032
TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.
Hurst LA, Dunmore BJ, Long L, Crosby A, Al-Lamki R, Deighton J, Southwood M, Yang X, Nikolic MZ, Herrera B, Inman GJ, Bradley JR, Rana AA, Upton PD, Morrell NW
Nature communications 2017 Jan 13;8:14079
Nature communications 2017 Jan 13;8:14079
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice.
Meynard D, Vaja V, Sun CC, Corradini E, Chen S, López-Otín C, Grgurevic L, Hong CC, Stirnberg M, Gütschow M, Vukicevic S, Babitt JL, Lin HY
Blood 2011 Jul 21;118(3):747-56
Blood 2011 Jul 21;118(3):747-56
Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET
Cancer research 2005 Sep 15;65(18):8274-85
Cancer research 2005 Sep 15;65(18):8274-85
No comments: Submit comment
No validations: Submit validation data